Company / Inventory
Protalix BioTherapeutics, Inc. Inventory History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$25.7M
FY2025
5-year range
$16.8M / $25.7M
FY2021-FY2025
Trend
+21.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has increased for 3 consecutive years, from $17M in FY2022 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 10-year CAGR of +16.1%.
Improved from $19M to $26M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- +15.3%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- +16.1%
Key checks
Key Insights
- Protalix BioTherapeutics, Inc.'s inventory has grown for 3 consecutive years.
- 5-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, inventory increased 21.1% year-over-year.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.7M | +21.1% |
| FY2024 | $21.2M | +11.5% |
| FY2023 | $19.0M | +13.3% |
| FY2022 | $16.8M | -6.4% |
| FY2021 | $18.0M | +37.2% |
| FY2020 | $13.1M | +60.4% |
| FY2019 | $8.2M | +4.1% |
| FY2017 | $7.8M | +49.3% |
| FY2016 | $5.2M | -9.1% |
| FY2015 | $5.8M | -13.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026